Medtronic
MDT
1,987 hedge funds and large institutions have $88B invested in Medtronic in 2023 Q1 according to their latest regulatory filings, with 157 funds opening new positions, 992 increasing their positions, 623 reducing their positions, and 118 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 992 | Existing positions reduced: 623
33% more first-time investments, than exits
New positions opened: 157 | Existing positions closed: 118
20% more call options, than puts
Call options by funds: $666M | Put options by funds: $555M
17% more capital inflows, than outflows
Capital inflows: $4.59B | Capital outflows: $3.93B
1% more funds holding
Funds holding: 1,958 → 1,987 (+29)
0.57% more ownership
Funds ownership: 81.42% → 81.99% (+0.57%)
13% less funds holding in top 10
Funds holding in top 10: 31 → 27 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$281M |
| 2 |
First Eagle Investment Management
New York
|
+$271M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$252M |
| 4 |
Cullen Capital Management
New York
|
+$246M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$234M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$375M |
| 2 |
Barclays
London,
United Kingdom
|
-$341M |
| 3 |
D.E. Shaw & Co
New York
|
-$198M |
| 4 |
Two Sigma Investments
New York
|
-$162M |
| 5 |
Renaissance Technologies
New York
|
-$136M |
MDT Hedge Fund Activity: Q1 2023 in Review
1,987 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2023, worth a combined $88B — up 4.5% from $84.2B a quarter earlier.
Buyers outnumbered sellers: 157 funds opened new MDT positions and 118 closed out — a net gain of 39 holders — while 992 added to existing stakes and 623 trimmed.
The largest buyer was Ameriprise, adding an estimated $281M. The largest seller was BlackRock, cutting an estimated $375M.
- 1,987 institutional investors held Medtronic (MDT) as of Q1 2023, up from 1,958 in Q4 2022.
- Funds reported $88B of Medtronic stock for Q1 2023, up 4.5% quarter-over-quarter.
- 157 funds opened new Medtronic positions in Q1 2023 and 118 closed out, a net change of +39 holders.
- The largest Medtronic buyer in Q1 2023 was Ameriprise, an estimated $281M added.
- The largest Medtronic seller in Q1 2023 was BlackRock, an estimated $375M sold.
Based on aggregated 13F filings for Q1 2023.